Fundraising FoxCoeptis Pharmaceuticals
Wexford, US · Founded 2018 · Delaware corporation
Find your way into Coeptis Pharmaceuticals
Sign up to see every warm intro you have to Coeptis Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Coeptis Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 2 of 3 rounds · 2018–2021
▶$597KraisedJan 2021 · 9 investors · PharmaceuticalsRule 506(b)
▶$597KraisedJan 2021 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christine SheehyExecutive Officer, Director
- Dan YeraceExecutive Officer, Director
- David MehalickExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $597K
- Minimum investment
- $10K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$917.5KraisedDec 2020 · 16 investors · PharmaceuticalsRule 506(b)
▶$917.5KraisedDec 2020 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christine SheehyExecutive Officer, Director
- Dan YeraceExecutive Officer, Director
- David MehalickExecutive Officer, Director, Promoter
- Offering amount
- $917.5K
- Amount sold
- $917.5K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$18MofferedNov 2018 · PharmaceuticalsRule 506(b)
▶$18MofferedNov 2018 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David MehalickExecutive Officer, Director, Promoter
- Dan YeraceExecutive Officer, Director
- Offering amount
- $18M
- Minimum investment
- $60K
- Sales commissions
- $1.8M
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Coeptis Pharmaceuticals raised?
- Coeptis Pharmaceuticals has disclosed $1.5M raised across 2 of its 3 known rounds.
- Where is Coeptis Pharmaceuticals headquartered?
- Coeptis Pharmaceuticals is headquartered in Wexford, US.